A common haplotype at the 5′ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression

Paola Griseri, Tiziana Bachetti, Francesca Puppo, Francesca Lantieri, Roberto Ravazzolo, Marcella Devoto, Isabella Ceccherini

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Hirschsprung disease (HSCR) is a complex genetic defect of intestinal innervation mainly ascribed to loss of function mutations of the RET gene. Although RETcoding mutations account for only 15% of HSCR sporadic cases, several linkage and association studies still indicate RET as a major HSCR gene, suggesting the existence of noncoding RET variants or common polymorphisms which can act in HSCR pathogenesis. We previously described a predisposing RET haplotype (A-C-A) composed of alleles at three SNPs (-1 bp and -5 bp from the RET transcription start site, NT_033985.6:g.975824G > A and NT_033985.6:g.975820C > A, respectively, and silent polymorphism c.135G > A), which was present in 62% of chromosomes from HSCR patients but only in 22% of control chromosomes. Here we address the question of how this 5′ ACA haplotype may functionally act as a predisposing factor in HSCR pathogenesis by performing functional analysis of the same three SNPs. We demonstrate that neither the two promoter variants nor the exon 2 SNP interfere with reporter gene transcription or RET mRNA splicing, respectively. However, real-time RT-PCR, performed in RNA obtained from lymphoblasts of selected individuals, has shown that homozygosity for the whole ACA haplotype is associated with reduced RET gene expression. We propose that a yet unidentified variant in linkage disequilibrium with the ACA haplotype, rather than the single characterizing SNPs, acts as a HSCR susceptibility allele by affecting the normal amount of RET receptor on the cell surface.

Original languageEnglish
Pages (from-to)189-195
Number of pages7
JournalHuman Mutation
Volume25
Issue number2
DOIs
Publication statusPublished - 2005

Fingerprint

Hirschsprung Disease
Proto-Oncogenes
Haplotypes
Gene Expression
Single Nucleotide Polymorphism
Alleles
Chromosomes, Human, Pair 22
Mutation
Transcription Initiation Site
Disease Susceptibility
Linkage Disequilibrium
Cell Surface Receptors
Reporter Genes
Causality
Genes
Real-Time Polymerase Chain Reaction
Exons
Chromosomes
RNA
Messenger RNA

Keywords

  • Expression
  • Haplotypes
  • HSCR
  • Promoter
  • RET
  • SNP

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

A common haplotype at the 5′ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. / Griseri, Paola; Bachetti, Tiziana; Puppo, Francesca; Lantieri, Francesca; Ravazzolo, Roberto; Devoto, Marcella; Ceccherini, Isabella.

In: Human Mutation, Vol. 25, No. 2, 2005, p. 189-195.

Research output: Contribution to journalArticle

Griseri, Paola ; Bachetti, Tiziana ; Puppo, Francesca ; Lantieri, Francesca ; Ravazzolo, Roberto ; Devoto, Marcella ; Ceccherini, Isabella. / A common haplotype at the 5′ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. In: Human Mutation. 2005 ; Vol. 25, No. 2. pp. 189-195.
@article{094f1d281aa04883a72051d54ae4906f,
title = "A common haplotype at the 5′ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression",
abstract = "Hirschsprung disease (HSCR) is a complex genetic defect of intestinal innervation mainly ascribed to loss of function mutations of the RET gene. Although RETcoding mutations account for only 15{\%} of HSCR sporadic cases, several linkage and association studies still indicate RET as a major HSCR gene, suggesting the existence of noncoding RET variants or common polymorphisms which can act in HSCR pathogenesis. We previously described a predisposing RET haplotype (A-C-A) composed of alleles at three SNPs (-1 bp and -5 bp from the RET transcription start site, NT_033985.6:g.975824G > A and NT_033985.6:g.975820C > A, respectively, and silent polymorphism c.135G > A), which was present in 62{\%} of chromosomes from HSCR patients but only in 22{\%} of control chromosomes. Here we address the question of how this 5′ ACA haplotype may functionally act as a predisposing factor in HSCR pathogenesis by performing functional analysis of the same three SNPs. We demonstrate that neither the two promoter variants nor the exon 2 SNP interfere with reporter gene transcription or RET mRNA splicing, respectively. However, real-time RT-PCR, performed in RNA obtained from lymphoblasts of selected individuals, has shown that homozygosity for the whole ACA haplotype is associated with reduced RET gene expression. We propose that a yet unidentified variant in linkage disequilibrium with the ACA haplotype, rather than the single characterizing SNPs, acts as a HSCR susceptibility allele by affecting the normal amount of RET receptor on the cell surface.",
keywords = "Expression, Haplotypes, HSCR, Promoter, RET, SNP",
author = "Paola Griseri and Tiziana Bachetti and Francesca Puppo and Francesca Lantieri and Roberto Ravazzolo and Marcella Devoto and Isabella Ceccherini",
year = "2005",
doi = "10.1002/humu.20135",
language = "English",
volume = "25",
pages = "189--195",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - A common haplotype at the 5′ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression

AU - Griseri, Paola

AU - Bachetti, Tiziana

AU - Puppo, Francesca

AU - Lantieri, Francesca

AU - Ravazzolo, Roberto

AU - Devoto, Marcella

AU - Ceccherini, Isabella

PY - 2005

Y1 - 2005

N2 - Hirschsprung disease (HSCR) is a complex genetic defect of intestinal innervation mainly ascribed to loss of function mutations of the RET gene. Although RETcoding mutations account for only 15% of HSCR sporadic cases, several linkage and association studies still indicate RET as a major HSCR gene, suggesting the existence of noncoding RET variants or common polymorphisms which can act in HSCR pathogenesis. We previously described a predisposing RET haplotype (A-C-A) composed of alleles at three SNPs (-1 bp and -5 bp from the RET transcription start site, NT_033985.6:g.975824G > A and NT_033985.6:g.975820C > A, respectively, and silent polymorphism c.135G > A), which was present in 62% of chromosomes from HSCR patients but only in 22% of control chromosomes. Here we address the question of how this 5′ ACA haplotype may functionally act as a predisposing factor in HSCR pathogenesis by performing functional analysis of the same three SNPs. We demonstrate that neither the two promoter variants nor the exon 2 SNP interfere with reporter gene transcription or RET mRNA splicing, respectively. However, real-time RT-PCR, performed in RNA obtained from lymphoblasts of selected individuals, has shown that homozygosity for the whole ACA haplotype is associated with reduced RET gene expression. We propose that a yet unidentified variant in linkage disequilibrium with the ACA haplotype, rather than the single characterizing SNPs, acts as a HSCR susceptibility allele by affecting the normal amount of RET receptor on the cell surface.

AB - Hirschsprung disease (HSCR) is a complex genetic defect of intestinal innervation mainly ascribed to loss of function mutations of the RET gene. Although RETcoding mutations account for only 15% of HSCR sporadic cases, several linkage and association studies still indicate RET as a major HSCR gene, suggesting the existence of noncoding RET variants or common polymorphisms which can act in HSCR pathogenesis. We previously described a predisposing RET haplotype (A-C-A) composed of alleles at three SNPs (-1 bp and -5 bp from the RET transcription start site, NT_033985.6:g.975824G > A and NT_033985.6:g.975820C > A, respectively, and silent polymorphism c.135G > A), which was present in 62% of chromosomes from HSCR patients but only in 22% of control chromosomes. Here we address the question of how this 5′ ACA haplotype may functionally act as a predisposing factor in HSCR pathogenesis by performing functional analysis of the same three SNPs. We demonstrate that neither the two promoter variants nor the exon 2 SNP interfere with reporter gene transcription or RET mRNA splicing, respectively. However, real-time RT-PCR, performed in RNA obtained from lymphoblasts of selected individuals, has shown that homozygosity for the whole ACA haplotype is associated with reduced RET gene expression. We propose that a yet unidentified variant in linkage disequilibrium with the ACA haplotype, rather than the single characterizing SNPs, acts as a HSCR susceptibility allele by affecting the normal amount of RET receptor on the cell surface.

KW - Expression

KW - Haplotypes

KW - HSCR

KW - Promoter

KW - RET

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=13444311533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444311533&partnerID=8YFLogxK

U2 - 10.1002/humu.20135

DO - 10.1002/humu.20135

M3 - Article

C2 - 15643606

AN - SCOPUS:13444311533

VL - 25

SP - 189

EP - 195

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 2

ER -